COLLEEN COSTELLOE to Dasatinib
This is a "connection" page, showing publications COLLEEN COSTELLOE has written about Dasatinib.
Connection Strength
0.107
-
TBCRC-010: Phase I/II Study of Dasatinib in Combination with Zoledronic Acid for the Treatment of Breast Cancer Bone Metastasis. Clin Cancer Res. 2016 Dec 01; 22(23):5706-5712.
Score: 0.107